BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ExonHit Therapeutics Inc. 

Avenel Business Park
217 Perry Parkway
Gaithersburg  Maryland  20877  U.S.A.
Phone: 240-683-7070 Fax: 240-683-7060


SEARCH JOBS


Industry
Services






 Company News
ExonHit Therapeutics Inc. Receives € 1.93 Million from OSEO Within the Personalized Medicine TEDAC Project in Cancer 6/5/2012 10:32:56 AM    More...
ExonHit Therapeutics Inc. is Beneficiary of a Grant from the European Union Within the Responsify Consortium 3/5/2012 10:09:13 AM    More...
ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France 12/12/2011 10:49:57 AM    More...
ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc. (AGN) 11/2/2011 7:39:45 AM    More...
Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis 10/26/2011 11:14:59 AM    More...
ExonHit Therapeutics Inc. and Beijing Genomics Institute (BGI) Announce Successful Completion of a Promising Next-Generation Sequencing Project 7/25/2011 11:00:10 AM    More...
ExonHit Therapeutics Inc. Announces Successful Completion of the Second Phase of EHT Dx14 Clinical Validation 7/19/2011 11:12:45 AM    More...
ExonHit Therapeutics Inc. Reports Key Progress in the Introduction of AclarusDx(TM) in the French IVD Market 6/29/2011 10:53:00 AM    More...
ExonHit Therapeutics Inc.'s Extraordinary Shareholders’ Meeting 5/18/2011 10:33:53 AM    More...
ExonHit Therapeutics Inc. Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer Research 4/5/2011 10:41:15 AM    More...
12345

//-->